Trials / Unknown
UnknownNCT03501459
Lymphocyte Markers As Predictors Of Responsiveness To Rituximab Among Patients With Idiopathic Nephrotic Syndrome
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- National University Health System, Singapore · Academic / Other
- Sex
- All
- Age
- 1 Year
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate if lymphocyte markers predict response to rituximab among patients with idiopathic nephrotic syndrome
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rituximab |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2020-12-01
- Completion
- 2025-12-01
- First posted
- 2018-04-18
- Last updated
- 2019-08-28
Locations
1 site across 1 country: Singapore
Source: ClinicalTrials.gov record NCT03501459. Inclusion in this directory is not an endorsement.